Literature DB >> 2525116

Microbial flora in the gastrointestinal tract abolishes cytostatic effects of alpha-difluoromethylornithine in vivo.

J Hessels1, A W Kingma, H Ferwerda, J Keij, G A van den Berg, F A Muskiet.   

Abstract

Although treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) leads to depletion of intracellular polyamines and to related growth inhibition in vitro, its cytostatic effects in vivo are disappointing. This may be due to abolition of DFMO-induced growth inhibition by polyamines released during normal body cell turnover, to dietary polyamines, or to putrescine synthesized by the microbial flora in the GI tract. We studied selectively (aerobic) and totally (aerobic + anaerobic) GI tract-decontaminated LI210-bearing mice fed with 3 types of diet differing in their polyamine and carbohydrate residue contents and treated with combinations of intraperitoneal DFMO and oral deuterium-labelled putrescine. Our data show that, irrespective of diet type, total decontamination markedly potentiates the moderate tumor growth inhibition that is caused by DFMO alone. During total decontamination, growth-inhibited L1210 cells accumulate in the G0/G1 phase of the cell cycle. Although orally administered deuterium-labelled putrescine gave rise to deuterium labelling of L1210 putrescine, spermidine and spermine, the polyamine levels in our diets played only a minor role.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525116     DOI: 10.1002/ijc.2910430632

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Tumor attenuation by combined heparan sulfate and polyamine depletion.

Authors:  Mattias Belting; Lubor Borsig; Mark M Fuster; Jillian R Brown; Lo Persson; Lars-Ake Fransson; Jeffrey D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development.

Authors:  C Löser; A Eisel; D Harms; U R Fölsch
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Polyamine transport systems in mammalian cells and tissues.

Authors:  Takeshi Uemura; Eugene W Gerner
Journal:  Methods Mol Biol       Date:  2011

4.  Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract.

Authors:  Takeshi Uemura; David E Stringer; Karen A Blohm-Mangone; Eugene W Gerner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

5.  Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.

Authors:  E W Gerner
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

6.  Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies.

Authors:  R R Streiff; J F Bender
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

7.  Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.

Authors:  Candace S Hayes; Allyson C Shicora; Martin P Keough; Adam E Snook; Mark R Burns; Susan K Gilmour
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

8.  Identification and characterization of a diamine exporter in colon epithelial cells.

Authors:  Takeshi Uemura; Hagit F Yerushalmi; George Tsaprailis; David E Stringer; Kirk E Pastorian; Leo Hawel; Craig V Byus; Eugene W Gerner
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

Review 9.  A perspective of polyamine metabolism.

Authors:  Heather M Wallace; Alison V Fraser; Alun Hughes
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

Review 10.  Polyamines in brain tumor therapy.

Authors:  E S Redgate; S Boggs; A Grudziak; M Deutsch
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.